SCHEMBL2593549

SCHEMBL2593549

Fc1ccc(-c2nc3ccccn3c2P(=S)(c2ccccc2)c2ccccc2)cc1

nearest known ligand 0.58

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
NPSR1 Q6W5P4 3/20 0.58
ALDH1A1 P00352 4/20 0.54
KDM4E B2RXH2 4/20 0.49
HPGD P15428 2/20 0.49
NPC1 O15118 3/20 0.46
RAB9A P51151 3/20 0.46
FLT3 P36888 1/20 0.43
MAPT P10636 4/20 0.43
GAA P10253 3/20 0.43
TP53 P04637 1/20 0.42
NPY1R P25929 1/20 0.42
NPY2R P49146 1/20 0.42
MAPK13 O15264 1/20 0.41
MAPK12 P53778 1/20 0.41
MAPK11 Q15759 1/20 0.41
MAPK14 Q16539 1/20 0.41
NR1I3 Q14994 1/20 0.41
PKM P14618 1/20 0.40
PKLR P30613 1/20 0.40
ADRA1B P35368 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL22342526 0.76 ALDH1A1 (0.61) ALDH1A1KDM4EHPGDNPC1RAB9A
SCHEMBL2582202 0.74 NPSR1 (1.00) NPSR1ALDH1A1KDM4EHPGDNPC1
SCHEMBL22627410 0.74 NPC1 (0.72) ALDH1A1KDM4EHPGDNPC1RAB9A
SCHEMBL8874253 0.74 RAB9A (0.76) ALDH1A1KDM4EHPGDNPC1RAB9A
SCHEMBL1050868 0.74 ALDH1A1 (0.62) NPSR1ALDH1A1KDM4EHPGDNPC1
SCHEMBL15825411 0.74 ALDH1A1 (0.62) ALDH1A1KDM4EHPGDNPC1RAB9A
SCHEMBL22615058 0.74 ALDH1A1 (0.62) ALDH1A1KDM4EHPGDNPC1RAB9A
SCHEMBL14705971 0.72 ALDH1A1 (0.61) ALDH1A1KDM4EHPGDNPC1RAB9A
SCHEMBL14022520 0.71 GAA (0.67) ALDH1A1KDM4EHPGDMAPTGAA
SCHEMBL1967979 0.71 TUBB4A (0.64) ALDH1A1KDM4EHPGDMAPTGAA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2011137220-A1 SMALL MOLECULE NEUROPEPTIDE S ANTAGONISTS FOR THE TREATMENT OF ADDICTIVE DISORDERS, MOOD, ANXIETY AND SLEEP DISORDERS THE UNITED STATES OF AMERICA, AS REPRESENTED BY THE SECRETARY, DEPARTMENT OF HEALTH AND HUMAN SERVICES (US) 2011-11-03 WO disclosed
WO-2011137220-A1 SMALL MOLECULE NEUROPEPTIDE S ANTAGONISTS FOR THE TREATMENT OF ADDICTIVE DISORDERS, MOOD, ANXIETY AND SLEEP DISORDERS THE UNITED STATES OF AMERICA, AS REPRESENTED BY THE SECRETARY, DEPARTMENT OF HEALTH AND HUMAN SERVICES (US) 2011-11-03 WO disclosed